BridgeMD
New treatment option for Hydration Status
Official title The Effect of Hydration Status on Substrate Oxidation at Rest and During Light and Moderate Exercise
ClinicalTrials.gov ID: NCT07298863
What this study is testing
- What it's testing
- Metabolic flexibility is the ability to properly switch between fat and carbohydrate stores to use for energy under different conditions (rest, feeding, exercise). Impairments in metabolic flexibility, also known as metabolic inflexibility, have been suggested to be an underlying cause of metabolic disease, like type 2 diabetes.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 35. Healthy volunteers may be eligible.
You may be able to join if
- Subject is male or female
- If female, subject is not pregnant (based on self-report)
- If female, subject has stopped taking birth control medication or removed long-acting reversible contraceptive \>6 months at start of the study
- If female, subject has normal menstrual cycle (21-35 days)
- If female, subject is willing to track their menstrual cycle
You likely can't join if
- Subject has participated in a clinical trial within the past 30 days
- Subject has participated in any PepsiCo trial within past 36 months
- Subject has a condition or is taking medication that the investigator believes would interfere with his/her ability to provide informed consent...
- Subject is allergic to alcohol (alcohol pre pads are used for blood draws
- If female, subject is taking birth control medication or has long-acting reversible contraceptive
- If male, subject is undergoing hormone therapy to alter testosterone levels (injections, transdermal patch, pill, etc.)
See the full eligibility criteria
- Subject is male or female
- If female, subject is not pregnant (based on self-report)
- If female, subject has stopped taking birth control medication or removed long-acting reversible contraceptive \>6 months at start of the study
- If female, subject has normal menstrual cycle (21-35 days)
- If female, subject is willing to track their menstrual cycle
- If female, subject has a smartphone compatible for application to track menstrual cycle (female only) and/or wearable data (females and males)
- Subject is 18-35 years of age, inclusive
- Subject body mass index (BMI) is between 18.5-25 kg/m2
- Subject is at least recreationally active (engaged in moderate-intensity, intermittent, or steady-state exercise at least 3 days per week for at least 60 min at a time)
- Subject is accustomed to cycling for at least 60 min
- Subject does not smoke (or has quit for at least 6 months)
- Subject is not taking medication that may interfere with the study (e.g., diuretics, laxatives, or weight loss drugs)
- Subject has no health conditions that would interfere with the study as indicated on the general health questionnaire (GHQ) e.g. cardiovascular, renal, or metabolic diseases
- Subject is not actively involved in weight loss intervention (dieting and/or anti-obesity medications)
- Subject is not allergic to adhesives (e.g., medical tape)
- Subject is willing to avoid alcohol consumption 24 hours prior to visit(s)
- Subject is willing to fast overnight (\~8-12 hours)
- Subject is willing to refrain from vigorous exercise for 24 hours (light physical activity only)
- Subject is willing to be shaved at patch or electrode site, if necessary
- Subject is willing to eat the exact same food the day prior to each visit to the laboratory
- Able to speak, write, and read English
- Provision of written consent to participate
- Subject has participated in a clinical trial within the past 30 days
- Subject has participated in any PepsiCo trial within past 36 months
- Subject has a condition or is taking medication that the investigator believes would interfere with his/her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of...
- Subject is allergic to alcohol (alcohol pre pads are used for blood draws
- If female, subject is taking birth control medication or has long-acting reversible contraceptive
- If male, subject is undergoing hormone therapy to alter testosterone levels (injections, transdermal patch, pill, etc.)
- Subject is employed by, or has a parent, guardian, or other immediate family member employed by a company that manufactures any products that compete with any Gatorade product. If subject is unsure if a company would be...
The study team makes the final eligibility decision.
Where it's taking place
- Valhalla, New York, United States
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 35 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Valhalla, New York, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.